AlphaYouSR
Insider selling
Simrat Randhawa sold Dianthus Therapeutics, Inc. /DE/ (DNTH) stock
Simrat Randhawa, EVP, Head of R&D of Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 26,530 shares of DNTH stock, per an SEC Form 4 filed Jun 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 1, 2026, 1 day before it was made public.
DNTH has moved +7.8% since the trade date, from $89.45 to $96.47 (Sep 21, 2026 close).
- Traded
- Jun 1, 2026
- Disclosed
- Jun 2, 2026
- Filing delay
- 1 day
- Price since
- +7.8%
- Role
- EVP, Head of R&D
- Source
- SEC Form 4
More DNTH insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.